Hisamitsu Pharmaceutical Co (TSE:4530) EV-to-EBITDA : 8.66 (As of May. 12, 2024)

Hisamitsu Pharmaceutical Co EV-to-EBITDA Chart

Hisamitsu Pharmaceutical Co Annual Data
	Trend	Feb15	Feb16	Feb17	Feb18	Feb19	Feb20	Feb21	Feb22	Feb23	Feb24
EV-to-EBITDA		Get a 7-Day Free Trial					8.42	25.16	8.88	7.80	7.07

Hisamitsu Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EV-to-EBITDA	Get a 7-Day Free Trial															7.80	7.51	13.01	11.79	-

Competitive Comparison of Hisamitsu Pharmaceutical Co's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Hisamitsu Pharmaceutical Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Hisamitsu Pharmaceutical Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hisamitsu Pharmaceutical Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Hisamitsu Pharmaceutical Co's EV-to-EBITDA falls into.

Hisamitsu Pharmaceutical Co EV-to-EBITDA Calculation

Hisamitsu Pharmaceutical Co's EV-to-EBITDA for today is calculated as:

Hisamitsu Pharmaceutical Co's current Enterprise Value is 円166,345 Mil.
Hisamitsu Pharmaceutical Co's EBITDA for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円19,204 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hisamitsu Pharmaceutical Co  (TSE:4530) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Hisamitsu Pharmaceutical Co's PE Ratio for today is calculated as:

Hisamitsu Pharmaceutical Co's share price for today is 円3823.00.
Hisamitsu Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Nov. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円181.024.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Hisamitsu Pharmaceutical Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Hisamitsu Pharmaceutical Co (TSE:4530) Business Description